Heartbeam, Inc. Warrant

Five companies—VentriPoint Diagnostics, HeartBeam, Heartflow, Hyperfine, and GE Healthcare Technologies—are advancing AI-enabled cardiac diagnostic platforms to address the global heart disease crisis. Recent developments include VentriPoint's partnership with First Light Health for remote Indigenous communities, HeartBeam's collaboration wit...

A new report reveals the evolving cardiac diagnostics market, highlighting how consumer technology and medical systems are transforming heart monitoring, with a focus on intellectual property and diagnostic capabilities.

HeartBeam reported Q2 2025 results, showing a 23% decrease in cash burn and maintaining progress towards FDA clearance for its 12-lead ECG synthesis software, targeting a pilot launch in Florida and Southern California's concierge medical practices.